161 related articles for article (PubMed ID: 11907386)
1. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus typing in HIV-positive women.
Hameed M; Fernandes H; Skurnick J; Moore D; Kloser P; Heller D
Infect Dis Obstet Gynecol; 2001; 9(2):89-93. PubMed ID: 11495559
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
4. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
Apgar BS; Brotzman G
Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
[TBL] [Abstract][Full Text] [Related]
5. A comparison of uterine cervical cytology and biopsy results: indications and outcomes for colposcopy.
Swinker M; Cutlip AC; Ogle D
J Fam Pract; 1994 Jan; 38(1):40-4. PubMed ID: 8289050
[TBL] [Abstract][Full Text] [Related]
6. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
[TBL] [Abstract][Full Text] [Related]
8. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
9. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
Lillo FB; Lodini S; Ferrari D; Stayton C; Taccagni G; Galli L; Lazzarin A; Uberti-Foppa C
Clin Infect Dis; 2005 Feb; 40(3):451-7. PubMed ID: 15668870
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
Zhao C; Austin RM
Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
[TBL] [Abstract][Full Text] [Related]
11. The impact of high risk human papillomavirus testing in an inner London colposcopy clinic.
Perrons C; Brink N; Jalal H; Watts P; Jelley R
J Med Virol; 2005 Aug; 76(4):576-82. PubMed ID: 15977240
[TBL] [Abstract][Full Text] [Related]
12. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
13. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus.
Barzon L; Pizzighella S; Corti L; Mengoli C; Palù G
J Med Virol; 2002 Jul; 67(3):401-5. PubMed ID: 12116034
[TBL] [Abstract][Full Text] [Related]
14. [The evaluation of computer cytological test with colposcopy for the diagnosis of cervical lesions].
He Y; Wang Y; Lang J
Zhonghua Fu Chan Ke Za Zhi; 1998 May; 33(5):265-7. PubMed ID: 10682434
[TBL] [Abstract][Full Text] [Related]
15. [Use of the Digene Hybrid Capture System for identification of the human papillomavirus (HPV-Human Papillomavirus) in women with cervical dysplasia].
Kwaśniewska A; Semczuk M; Sikorski M; Kraczkowski J
Przegl Lek; 1997; 54(12):848-50. PubMed ID: 9591452
[TBL] [Abstract][Full Text] [Related]
16. Acetowhitening of the cervix and vulva as a predictor of subclinical human papillomavirus infection: sensitivity and specificity in a population-based study.
Jonsson M; Karlsson R; Evander M; Gustavsson A; Rylander E; Wadell G
Obstet Gynecol; 1997 Nov; 90(5):744-7. PubMed ID: 9351757
[TBL] [Abstract][Full Text] [Related]
17. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection.
Luque AE; Demeter LM; Reichman RC
J Infect Dis; 1999 Jun; 179(6):1405-9. PubMed ID: 10228061
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation.
Taube JM; Kamira B; Motevalli M; Nakabiito C; Lukande R; Kelly DP; Erozan YS; Gravitt PE; Buresh ME; Mmiro F; Bagenda D; Guay LA; Jackson JB
Diagn Cytopathol; 2010 Aug; 38(8):555-63. PubMed ID: 19937939
[TBL] [Abstract][Full Text] [Related]
19. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus.
Serwadda D; Wawer MJ; Shah KV; Sewankambo NK; Daniel R; Li C; Lorincz A; Meehan MP; Wabwire-Mangen F; Gray RH
J Infect Dis; 1999 Oct; 180(4):1316-9. PubMed ID: 10479163
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia.
Goff BA; Muntz HG; Bell DA; Wertheim I; Rice LW
Gynecol Oncol; 1993 Mar; 48(3):384-8. PubMed ID: 8385061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
